Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kristall plans to pay its first dividends in 2025

2/9/24 KLVZ

Nornickel management does not plan to pay dividends for 2023

2/9/24 GMKN

Novatek reports for 2023 by IFRS

2/9/24 NVTK

Board of Directors of NOVATEK recommended that dividends be paid for 2023

2/9/24 NVTK

Nornickel reported for 2023 by IFRS

2/9/24 GMKN

Yakovlev reported for 2023 by RAS

2/9/24 IRKT

Kamaz will develop hydrogen technologies in partnership with AFK Sistema

2/9/24 KMAZ

Sistema and Kamaz will develop hydrogen technologies

2/9/24 AFKS

Aeroflot's passenger turnover in January increased by 20.9%

2/9/24 AFLT

Tinkoff may create its own pension fund

2/9/24 T